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Effect of selenium supplementation on the immune response of Trypanosoma brucei brucei infected 
rats was investigated. Twenty five (25) adult male albino rats divided into five groups of five rats each 
were used for this study. Groups A, B and C were fed 4, 8 and 16 part per million (ppm) selenium in their 
feed, respectively. Groups D and E were not given selenium supplementation. The supplementation 
started on day 0, followed by the infection of groups A, B, C and D with T. brucei brucei on day 14 post 
supplementation (PS). Immune response of the rats was assessed by determining the antibody 
response to sheep red blood cells (SRBC) using direct haemagglutination technique and total and 
differential leucocyte counts. The supplementation led to significant (p < 0.05) increase in antibody 
response to sheep red blood cell of the supplemented groups at pre- and post infection when compared 
with the control. The infection however, led to decrease in antibody titre but remained higher than the 
pre-supplementation titre. Also, the supplementation led to increase (p < 0.05) in leucocyte counts prior 
to infection on day 14 PS. The increase in total leucocyte count could be attributed to increase in 
lymphocyte and neutrophils. The mortality record showed that all rats (100%) in the infected, not 
supplemented group and 2 rats (40%) died from the 16 ppm group by day 42 PS. No rat died in 4, 8 ppm 
and not infected, not treated groups.   
 





Trypanosome infection of livestock and humans has been 
shown to result in: a reduced capacity to mount a primary 
humoral response to non trypanosome antigens; an 
inappropriate antibody response to trypanosome 
antigens; depressed T-cell proliferation to mitogen and 
trypanosome antigen; reduced cytokine production and 
inferior response to vaccination (Mansfield, 1995; 
Mackenzie et al., 1975; Taylor and Authié, 2004). 
Consequently, the infected host is rendered more 
susceptible to opportunistic or secondary infections 
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immunosuppressive effect in trypanosome infection was 
first reported by Godwin (1970) and Godwin et al. (1972) 
and is thought to be responsible for the hosts’ inability to 
clear trypanosomes after administration of trypanocidal 
drugs (Osma et al., 1992). Also, trypanosome-induced 
immunosuppression is considered one of the major 
mechanisms of evasion from the host’s immune defences 
by the parasite (Uzonna et al., 1998). The ability of the 
host to produced or not produced sound immune 
responses are thought to determine the relative 
resistance and susceptibility of the host and the outcome 
of infection. The underlying cellular mechanism(s) 
responsible for immunosuppression could be due to 
trypanosome-derived B lymphocyte mitogen responsible 





during the disease and possibly, for the ultimate 
suppression of B lymphocyte responses (Gómez-
Rodríguez et al., 2009).      
The immunosuppressive effect of trypanosome 
infection has made it necessary to investigate the effect 
of immunostimulants in overcoming trypanosome-
induced immunosuppression. Restoration of normal 
immune functions may increase resistance to infectious 
diseases and reduce the severity of disease. Trials with 
immunostimulants resulted in a significant reduction in 
early anaemia, a reduction in the first parasitemia peak, 
the absence of acute splenomegaly and finally, a delayed 
mortality (Murray and Morrison, 1979; Whitlaw et al., 
1983). Also, reduced weight loss, liver damage, acidosis 
and anaemia during infections by Trypanosoma brucei 
brucei were reported. For example, selenium, a trace 
mineral, is essential for good health but required only in 
small amounts (Goldhaber, 2003; Thomson, 2004).  
Enhanced immunity had been reported for dietary 
supplementation of selenium in animals (Walter and 
Jensen, 1963; Sidhu et al., 1993). Selenium influences 
both the innate “nonadaptive” and the acquired “adaptive” 
immune system (Kiremidjian-Shumacher and Roy, 1998; 
McKenzie et al., 2001; Bhaskaran, 2002; Beckett et al., 
2003). It appears to affect non-specific immune indices, 
humoral immunity, cellular immunity and cytotoxicity. 
Spallhoz et al. (1973) demonstrated that high dietary 
selenium enhanced serum immunoglobulin G (IgG) and 
immunoglobulin M (IgM) antibody titres in mice 
challenged with sheep red blood cells. Also, selenium 
supplementation increased survival time of mice infected 
with Candida albicans (Boyne and Arthur, 1986), in mice 
infected with Trypanosoma cruzi (Davies et al., 1991) and 
when combined with vitamin E increased survival interval 
of Trypanosoma congolense infected rats (Mgbenka and 
Ufele, 2004). In summary, selenium supplementation 
leads to increases in antibody response, T-cell proli-
feration and killing by macrophages, lymphocyte 
proliferation, expression of interleukin (IL)-2 receptor, and 
IL-2 production and also to an augmented cellular 
immune response to live vaccines (Roy 1994; McKenzie 
et al., 1998; Levander, 2000; Pagmantidis et al., 2008). 
Immune response to sheep red blood cells has been 
widely used in the study of animals’ immune status 
(Ikeme and Adelaja, 1990; Ihedioha et al., 2003). The use 
of sheep red blood cells (SRBC) challenge is based on 
the fact that, responses to it is T-dependent and T-cells 
(T-helper cells specificity) coordinate the battle against 
infection by activating macrophages, B-cells and other T-
cells and thus, indirectly control immunoglobulin pro-
duction (ILRAD, 1992; Sherman and Halliquest, 1990). 
The method has been used successfully to investigate 
trypanosomal immunosuppression by many researchers 
(Godwin et al., 1972; Hudson et al., 1976; Baltz et al., 
1981; Ekejindu et al., 1985; Ikeme and Adelaja, 1990; 
Ihedioha et al., 2003).  
This study was an attempt to  investigate  the  immuno- 




modulatory effect of selenium supplementation on 
leucocytic profile and antibody responses of T. brucei 
brucei infected rats. 
 
 




25 adult male outbreed albino rats weighing between 278 to 302 g 
were used for this study. The rats were acquired from the 
Laboratory Animal unit of the Department of Veterinary Pathology 
and Microbiology, University of Nigeria, Nsukka. The rats were 
housed in a fly proofed house and given feed and water ad libitum. 





T. brucei brucei (Federe strain) used for this study was obtained 
from the National Institute for Trypanosomiasis Research (NITR), 
Vom Nigeria. The strain was isolated from N’dama cattle from 
Federe village in Plateau State, Nigeria and has been maintained in 
liquid nitrogen at the NITR Vom. The strain was passage in rats 





Selenium as sodium selenite was manufactured by Biorganics 
Nigeria Limited, Ikeja-Lagos, Nigeria. 
 
 
Sheep red blood cells (SRBC) 
 
Fresh sheep blood was obtained from sheep in the Animal house of 
Department of Veterinary Parasitology and Entomology, University 
of Nigeria through their jugular vein. Before use, the red blood cells 
were washed three times with about 1 part of blood to 9 parts of 
phosphate-buffered saline (PBS), pH 7.2, by centrifugation at 3000 
rpm for 10 min on each occasion. After the final wash, the SRBCs 
were suspended in PBS as a 2% suspension (based on packed cell 
volume) for the serological tests and as a 10% suspension for 
immunization of the rats. A 1 ml amount of the 2% suspension 





The rats were divided into five (5) groups (A, B, C, D and E) of 5 
rats each and each group received treatment as follows; groups A, 
B and C received 4, 8 and 16 part per million (ppm) selenium in 
their feed from day 0 till termination of the experiment. The 
selenium content of the feed was assayed for and made up to 4, 8 
and 16 ppm of the feed. On day 14 of post supplementation (PS), 
groups A, B, C and D rats were infected with 0.5 ml of saline diluted 
trypanosome infected rat blood containing 1 X 106 trypanosomes 
intraperitoneally.  All the rat groups A, B, C, D and E were given 0.3 
ml of sheep red blood cells (SRBC) per rat 7 days before 
supplementation with repeats every other 14th day.  
The immune responses of the rats were assessed using serum 
antibody response to sheep red blood cells (SRBC), total leucocyte 
count and differential leucocyte count. 
 
 
Immunization of rats with SRBCs 
 
Immunization was achieved by an initial intraperitoneal injection of  




Table 1. Mean antibody titre of rat groups supplemented with different levels of selenium in their feed and controls. 
 
Experimental day 4 ppm 8 ppm 16 ppm Infected not supplemented 
Not infected, not  
supplemented 
0 25.60 (10.6) 30.40 (9.60) 25.6 (3.92) 28.8 (10.3) 22.4 (3.92) 
14 32.00a (8.76) 38.40a (10.9) 57.60a (18.7) 22.40b (3.92) 20.80b (4.80) 
28 102.4a (15.7) 153.6a (43.4) 166.4a (38.4) 32.00b (8.76) 36.80b (8.76) 
42 89.90a (15.6) 102.4a (15.7) 128.0a (35.1) - 22.4b (3.92) 
 
Day 0 was 7 days after the first immunization and the day supplementation started, day 14 was day of infection. a and b, Means within 




0.3 ml of a 10% sheep red blood cells suspension in normal saline. 
This was followed by booster doses every other 14th day during the 
experimental period.  
 
 
Collection of blood sample from rats 
 
About 0.5 ml of blood was collected from the retro bulbar plexus of 
the medial canthus of rats. 0.2 ml of the blood was put into 
anticoagulant bottle for leucocyte count, while the remainder was 
put in Eppendorf tube, allowed to clot and later centrifuged at 
15,000 revolutions per minute (rpm) for 10 min to separate the 




Determination of total and differential leucocyte counts 
 
The total leucocyte count was determined using the procedures 
described by Schalm et al. (1975) whereas the differential leucocyte 
count was determined by putting a drop of blood on a clean slide 
and thin smear made. The smear was air dried and stained with 
Leishman stain. The slides were examined under oil stained 
immersion objective light microscope. 100 cells were counted by 
the longitudinal counting method. The number of each cell type 
(neutrophil, lymphocyte, monocyte, eosinophil and basophil) 
counted among the 100 cells represent the percentage of each cell 
type. The percentage values were changed to absolute value by 
dividing the percentage value by 100 and multiplying by the total 
leucocyte count.  
 
 
Determination of antibody response to sheep red blood cells 
(SRBC) 
 
The antibody response to SRBC antigen was assayed for by direct 
haemaggluination technique (Ikeme and Adelaja, 1990). The test 
serum was initially diluted (1:8) to exclude non-specific 
isoagglutination of SRBC by normal rat serum. The microtitre plates 
were labelled according to the rat group names (A, B, C, D and E). 
25 microtitre of normal saline was pipetted into all the wells of each 
row except the first and penultimate wells. A 25 ml volume of the 
diluted test serum was pipetted into the first well. Another 25 ml of 
the test serum was pipetted into the second well this was used for 
doubling dilutions. The last well in each row contained 25 ml of 
normal rat serum control. To each well was added 25 ml of a 2% 
SRBC suspension. The content of the wells were mixed for one 
minute by gentle rocking of the plate. This was incubated at room 
temperature (27 to 30°C) for three hours after which the resulting 
agglutination titres were read and expressed as geometric mean 
titre.   
Statistical analysis 
 
The data obtained from this study were summarized as means ± 
standard error of means. Statistical comparisms between the 
treatment groups were made by one way analysis of variance 
(ANOVA). Means were considered significant at P < 0.05 and the 





The pre-infection supplementation with selenium 
prolonged the pre-patent interval from 4.30±0.12 days in 
group D to 5.23±0.18 days in group B, though, the 
difference was not statistically significant (p > 0.05) when 
compared with the control. The supplementation led to 
significant increase in antibody titre of supplemented 
groups when compared with the infected not 
supplemented and not infected not supplemented groups 
(Table 1). The 8 ppm group had significantly higher (p < 
0.05) antibody response on day 28 post supplementation 
when compared with other supplemented groups. The 
decrease in antibody titre of the supplemented groups by 
day 42 PS was higher than the pre-infection titre.  
The pre-infection supplementation with selenium led to 
significant increase in total leucocyte count by day 14 PS 
(Figure 1). Following infection on day 14 PS, the total 
leucocyte count decreased slightly but remained higher 
than the pre-supplementation level. The leucocyte count 
of the 8 and 16 ppm groups were significantly (p0.05) 
higher than the controls on days 21 and 35 PS.   
The differential leucocyte counts are shown in Figure 
2a, b, c, d and e. The lymphocyte count (Figure 2) 
increased significantly (p0.05) in all the supplemented 
groups from day 28 PS and remained high till the 
termination of the experiment on day 42 PS. Also, the 
supplementation increased neutrophil counts significantly 
(p0.05) in groups supplemented with 8 and 16 ppm 
when compared with other groups. The basophils, 
eosinophils and monocyte counts did not show any 
consistent pattern in their changes. However, the 
supplemented groups maintained higher counts than the 
infected not supplemented and not infected not 
supplemented groups. 
The mortality record showed that all rats (100%) with 
mean survival interval of 28.33±5.13 days in the  infected,  










not supplemented group died before day 42 PS, 
whereas2 rats (40%) died with mean  survival  interval  of 
39.00±4.69 days from the 16 ppm group by day 42 PS. 
No rat died in 4, 8 ppm and not infected, not treated 





Immunosuppression has been described  in  both  natural 
and experimental infections of humans and domestic 
mammals as well as laboratory rodents with 
trypanosomes (De Baetselier, 1996; Taylor, 1998) and is 
suggested to be responsible for the poor responsiveness 
of trypanosome-bearing hosts to vaccinations 
(Rurangirwa et al., 1978) as well as renders the infected 
host more susceptible to secondary infections (Holmes, 
1980). It  appears  to  be  a  nearly  universal  feature  of 
infection with African trypanosomes and thus, may 
represent an essential element of the  host-parasite  rela- 






Figure 2. Showing the mean lymphocyte (A), neutrophils (B), eosinophils (C) and basophils (D) of T. brucei infected rats 
receiving levels of dietary selenium supplementation. 












Figure 3. Survival intervals of rat groups supplemented with different levels of selenium. 




tionship, possibly by reducing the host’s ability to mount a 
protective immune response. Antibody, T cell and 
macrophage/monocyte responses of infected hosts are 
depressed (Taylor and Mertens, 1999). Lymphocytes 
from infected hosts give a lower response to T cell 
mitogens or allogeneic cells in vitro (Sileghem et al., 
1994). Low levels of T-cell independent, antitry-
panosomal antibodies are adequate to clear the 
bloodstream of parasites during DFMO therapy (Bitonti et 
al., 1986).    
From this study, pre-infection supplementation with 
selenium prolonged the pre-patent period of the 
supplemented groups. This may be attributed to the 
immunomodulatory and antioxidant activities of selenium 
(Bhaskaran, 2002; Beckett et al., 2003; Arthur et al., 
2003) which are necessary for the optimum function of 
both cellular and humoral immune processes. Earlier 
researchers demonstrated that, dietary supplementation 
with selenium and vitamin E enhanced immune response 
in white rats (Mgbenka and Ufele, 2004), enhanced the 
efficacy of diaminazine aceturate and isometamidium 
chloride in chemotherapy of murine trypanosomosis (Eze 
et al., 2009), reduced parasitaemia and prolonged 
survival interval in T. cruzi infected mice (Davis et 
al.,1998). Insufficient intake of selenium is thought to 
contribute to the pathogenesis of various degenerative 
and inflam-matory diseases, aging and cancer (Lee et al., 
1996).  
The increase in antibody titres of selenium 
supplemented groups is in agreement with works done by 
Larsen et al. (1988), Turner and Finch (1991) and Arshad 
et al. (2005). It has also been reported that feeding of 
animals with selenium deficient feed lowers the antibody 
response to antigen (Mulhern et al., 1985). Studies with 
small animals supplemented with 0.7 or 2.8 ppm 
selenium resulted in a 7 or 30-fold increase in antibody 
titers (sheep red blood cell antigen), respectively, over 
the non-supplemented group (Spallholz et al., 1975). The 
trypanosomes infection on day 14 PS did not cause 
decrease in antibody titres on day 28 PS, but by day 42 
PS, there was a decrease which is an indication that 
immunosuppression is a manifestation of chronic 
infection with trypanosomes. The decrease in antibody 
titre was however, higher than the pre-supplementation 
values. According to Hughes and Kelly (2006), prevention 
of infection relies predominantly on barrier function and 
innate immunity, whereas clearance of an established 
infection requires either a successful humoral response 
(for example, trypanosomiasis) or a successful cell-
mediated immune response (for example, 
schistosomiasis). Also, specific antibodies directed 
against the trypanosome VSG mediate the destruction 
and clearance of parasites in successive parasitemic 
waves and hence, contribute to antibody-mediated 
trypanotolerance. 
The pre-infection supplementation with selenium led to 





following infection with trypanosomes on day 14 PS. The 
increase in total leucocyte may be attributed to 
proliferation of neutrophils and eosinophils. Increase in 
total leucocyte count is an indication of improved immune 
response. In humans, selenium supplementation has 
been reported to lead to increases in lymphocyte 
proliferation, augmented cellular immune response to live 
attenuated polio vaccine virus and a greater clearance of 
the virus (Roy et al., 1994; Broome et al., 2004; 
Pagmantidis et al., 2008). The increase in leucocytes 
may be attributed to the fact that, antioxidant enzymes 
like selenium-containing glutathione peroxidase and 
thioredoxin reductase protect neutrophils, macrophages 
and other tissues from the free radicals damage and 
could lower the level of immunosuppressing lipid 
peroxides, alter arachidonic acid metabolism (Brambilla 
et al., 2008). Free radicals are mediators of cellular injury 
and are involved in the onset of cellular damage. 
Neutrophils with reduced glutathione peroxidase due to 
selenium deficiency are less able to defend themselves 
against the free radicals they release onto pathogens. 
The reports on the effect of selenium supplementation 
on total and differential leucocyte are not consistent. An 
experiment with aged mice showed that, sodium selenite 
supplementation above the normal levels of selenium 
could restore lymphocyte proliferation due to antigens to 
the levels of young adult mice. The different and 
contrasting effects that Se supplementation had on white 
blood cell and platelet selenoenzyme activities and the 
fact that, these were seen in only 60±70% of subjects 
may be indicative of a difference in metabolic need 
regulated at the level of Se dependent cell function 
(Brown and Arthur, 2001). The results indicated that the 
immunoenhancing effects of selenium in humans require 
supplementation above the replete levels produced by 
normal dietary intake (Kiremidjian-Schumacher et al., 
1994). It is also evident from clinical studies that, 
increasing Se intake, decreases infection rate and 
susceptibility to viral mutation, which might increase the 
virulence of the pathogen. 
The death of rats in the infected unsupplemented group 
is consistent with other reports that trypanosomosis is 
pathogenic to rats (Ihedioha et al., 2009; Eze et al., 
2009). Also, 2 rats died in the group that received 16 ppm 
selenium in their feed. The death in the later may be due 
to the toxicity of selenium at that level. However, Davis et 
al. (1998) did not record any death in mice that received 
16 ppm selenium in drinking water. The 16 ppm group 
recorded the highest antibody response which may be an 
indication that there is more to trypanosome pathology 
than immunosuppression. Increasing selenium above 
normal levels in young adult mice increased the bacteria-
killing activity of spleen lymphocytes by 22.3% (Roy et 
al., 1990). Also, immune reactions in trypanosomosis do 
not always lead to protection and are also involved in 
immunopathology   disorder  (Vincendeau  and  Bouteille, 





sible for clearing the African trypanosomes from the 
blood of infected animals, recent evidence suggests that 
the survival time of infected mice does not necessarily 
correlate with the ability of the animal to produce 
trypanosome-specific antibody. In other words, resistance 
as measured by survival time may not solely involve the 
specific humoral immune system. Selenium 
supplementation can quickly augment and/or restore 
effective immune functions, due to its stimulatory effect 
on white blood cells and activity of the thymus gland, thus 
enhancing the body’s resistance to infection (Broome et 
al., 2004). 
In conclusion, selenium supplementation at 4 and 8 
ppm improved the immune status of the supplemented 
rats and at higher dose of 16 ppm produced highest 
antibody titre and leucocytic proliferation, but led to death 
in 2 rats at the termination of the experiment. Thus, 
higher dose of selenium supplementation seem to 
provoke higher immune response but are toxic to 
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